Here's the live share price of Fredun Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Fredun Pharmaceuticals has gained 39.95% CAGR. Over the past year, the corresponding return has been 58.62%.
Fredun Pharmaceuticals’s current P/E of 24.75x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Fredun Pharmaceuticals | -1.55 | -2.98 | 50.00 | 74.55 | 58.62 | 5.75 | 39.95 |
Sun Pharmaceutical Industries | 1.26 | -1.54 | -1.84 | -8.63 | -12.42 | 21.00 | 26.54 |
Divi's Laboratories | -0.95 | -3.36 | -8.98 | 2.15 | 12.36 | 18.35 | 13.97 |
Torrent Pharmaceuticals | 3.67 | -0.21 | 15.74 | 12.38 | 5.98 | 34.21 | 22.46 |
Cipla | -1.95 | -4.57 | 1.97 | 0.23 | -7.83 | 12.69 | 14.78 |
Dr. Reddy's Laboratories | -0.19 | 1.83 | -0.73 | 8.11 | -1.64 | 16.47 | 5.10 |
Mankind Pharma | -0.36 | 0.10 | 11.33 | 7.91 | -3.44 | 21.59 | 12.45 |
Zydus Lifesciences | 1.00 | 2.15 | 9.70 | 12.82 | -0.91 | 43.13 | 22.18 |
Lupin | -2.37 | 1.94 | 3.86 | -5.60 | -8.22 | 45.63 | 14.54 |
Alkem Laboratories | 1.07 | 2.79 | 16.85 | 10.16 | -6.91 | 19.54 | 15.21 |
Aurobindo Pharma | 1.57 | 3.91 | 0.85 | -8.30 | -25.07 | 28.93 | 7.27 |
Abbott India | -2.31 | -4.05 | -2.69 | -2.65 | 6.79 | 19.22 | 13.60 |
Glenmark Pharmaceuticals | -2.83 | 3.20 | 19.70 | 35.18 | 17.93 | 73.81 | 33.80 |
Laurus Labs | 1.72 | 4.30 | 36.60 | 46.06 | 91.92 | 21.27 | 27.22 |
Biocon | 0 | 0.04 | 2.27 | 3.08 | -2.78 | 8.22 | -3.20 |
GlaxoSmithKline Pharmaceuticals | 0.72 | -1.46 | -12.97 | -4.32 | 1.26 | 25.24 | 11.64 |
Anthem Biosciences | -1.17 | -2.60 | 12.42 | 12.42 | 12.42 | 3.98 | 2.37 |
Ipca Laboratories | 5.91 | -0.93 | 3.49 | -4.52 | -4.75 | 16.65 | 5.37 |
Cohance Lifesciences | -9.04 | 0.09 | -8.26 | -23.33 | -27.95 | 27.29 | 19.61 |
Gland Pharma | -0.37 | 3.71 | 15.49 | 24.91 | 9.12 | -2.13 | 2.04 |
Over the last one year, Fredun Pharmaceuticals has gained 58.62% compared to peers like Sun Pharmaceutical Industries (-12.42%), Divi's Laboratories (12.36%), Torrent Pharmaceuticals (5.98%). From a 5 year perspective, Fredun Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (26.54%) and Divi's Laboratories (13.97%).
Day | SMA | EMA |
---|---|---|
5 | 1,235.01 | 1,237.25 |
10 | 1,247.59 | 1,235.76 |
20 | 1,232.43 | 1,209.08 |
50 | 1,087.01 | 1,102.09 |
100 | 922.97 | 984.19 |
200 | 812.89 | 887.86 |
In the latest quarter, Fredun Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 1.59%, FII holding unchanged at 0.00%, and public shareholding moved up to 49.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 22, 2025, 6:08 AM IST | Fredun Pharma - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exchange Board Of Ind |
Sep 09, 2025, 12:40 AM IST | Fredun Pharma - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201 |
Sep 09, 2025, 12:33 AM IST | Fredun Pharma - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2024-25 |
Sep 09, 2025, 12:30 AM IST | Fredun Pharma - Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM) |
Sep 09, 2025, 12:27 AM IST | Fredun Pharma - Submission Of The 38Th Annual Report Of Fredun Pharmaceuticals Limited For The Financial Year 2024-25. |
Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 451.71 Cr. and Equity Capital is Rs. 4.72 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Fredun Pharmaceuticals is ₹1,229.00 as on Sep 23, 2025.
The Fredun Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Fredun Pharmaceuticals is ₹580.29 Cr as on Sep 23, 2025.
Today’s highest and lowest price of Fredun Pharmaceuticals are ₹1,244.95 and ₹1,190.05.
The 52-week high/low is the highest and lowest price at which Fredun Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Fredun Pharmaceuticals is ₹1,340.00 and 52-week low of Fredun Pharmaceuticals is ₹635.00 as on Sep 23, 2025.
The Fredun Pharmaceuticals has shown returns of 1.01% over the past day, -2.98% for the past month, 50.0% over 3 months, 58.62% over 1 year, 5.75% across 3 years, and 39.95% over 5 years.
P/E ratio of and PB ratio of Fredun Pharmaceuticals are 24.75 and 4.43 on Sep 23, 2025. While the company gives a dividend yield of 0.06 per annum.